Inovalon to Preview New Quality Research for Dual Eligible Populations to U.S. Congress
Bipartisan Congressional Briefing Highlights Research into the Difficulties of Supporting Dual Eligible Populations
WASHINGTON, Oct. 21, 2014 /PRNewswire/ -- Inovalon, Inc., a leading technology company providing advanced analytics and data-driven intervention platforms to the healthcare industry, will preview new research into the dual eligible population at a bipartisan Congressional briefing sponsored by the Special Need Plan (SNP) Alliance. Inovalon will share findings from the new study, entitled "An Investigation of Medicare Advantage Dual Eligible Member Level Performance on CMS Five-Star Quality Measures," which is anticipated for broader release later this year.
"The size of the dataset for this research is unprecedented -- more than two million Medicare Advantage members -- providing new insights that will have a significant impact on future discussions around CMS Five-Star Quality Measures," said Christie Teigland, Ph.D., Director, Statistical Research at Inovalon, the study's principal investigator who will be presenting the findings. "The data highlight the real challenges in serving this population, and we're pleased that our research will contribute to the ongoing dialogue regarding accurate measurement of Medicare Advantage plan performance. The performance gaps identified in this study will support targeted efforts to improve outcomes and quality of care for this population."
Since the implementation of the Affordable Care Act, many have believed that dual eligible beneficiaries, representing more than nine million people in the U.S. who are covered by both Medicare and Medicaid, are more challenging to support. The full Inovalon study is designed to examine, for the first time, member-level performance variations within plans while controlling for member clinical, demographic, socio-economic, and community characteristics.
Inovalon conducted its research in collaboration with Cigna-HealthSpring, Wellcare, Healthfirst, Gateway Health, Blue Cross Blue Shield Minnesota and Blue Plus, Health Care Services Corporation (HCSC), the SNP Alliance and Medicaid Health Plans of America (MHPA).
The Inovalon research relies on member-level Medicare Advantage data extracted from Inovalon's Medical Outcomes Research for Effectiveness and Economics Registry (MORE² Registry®). MORE² contains information derived from more than 8.7 billion medical events generated by more than 112 million unique and de-identified members nationwide and 719,000 physicians. The data include age, gender, race/ethnicity and comprehensive information on diseases/diagnoses, chronic conditions, medical and pharmacy utilization, and a broad range of primary clinical data, amongst other data elements. Additionally, datasets were utilized that contained socioeconomic and sociodemographic characteristics, as well as community resources availability and other factors impacting health. This analysis is the most comprehensive study of dual eligible member populations to date.
About Inovalon
Inovalon is a leading technology company that combines advanced cloud-based data analytics and data-driven intervention platforms to achieve meaningful impact in clinical and quality outcomes, utilization, and financial performance across the healthcare landscape. Inovalon's unique achievement of value is delivered through the effective progression of Turning Data into Insight, and Insight into Action®. Large proprietary datasets, advanced integration technologies, sophisticated predictive analytics, and deep subject matter expertise deliver a seamless, end-to-end platform of technology and nationwide operations that bring the benefits of big data and large-scale analytics to the point of care. Driven by data, Inovalon uniquely identifies gaps in care, quality, data integrity, and financial performance -- while also bringing to bear the unique capabilities to resolve them. Supporting hundreds of healthcare organizations in 97.8% of U.S. counties and Puerto Rico, Inovalon's analytical and data-driven intervention platforms are informed by data pertaining to more than 719,000 physicians, 229,000 clinical facilities, and more than 112 million Americans, providing a powerful solution suite that drives high-value impact, improving quality and economics for health plans, ACOs, hospitals, physicians, patients, and researchers. For more information visit www.inovalon.com.
Contacts:
Inovalon, Inc.
Kim E. Collins
4321 Collington Road
Bowie, Maryland 20716
Phone: 301-809-4000 x1473
[email protected]
Greenough, on behalf of Inovalon, Inc.
Andrea LePain
Phone: 617-275-6526
[email protected]
Logo - http://photos.prnewswire.com/prnh/20141021/153370LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/inovalon-to-preview-new-quality-research-for-dual-eligible-populations-to-us-congress-177781359.html
SOURCE Inovalon, Inc.
Share this article